Literature DB >> 6840163

Haemodynamic and clinical effects of isosorbide-dinitrate in patients with severe effort angina on beta-blocking treatment.

G Jensen, F Trautner, S Rasmussen, B Hesse.   

Abstract

The effect of isosorbide-dinitrate (ISDN) 20 mg 4 times daily against placebo has been tested in 12 patients with stable effort induced angina pectoris receiving prophylactic treatment with metoprolol. ISDN did not decrease the attack rate or nitroglycerine consumption, nor was exercise tolerance increased after it. Left ventricular function, assessed by radionuclide ventriculography, increased in 6 out of 8 patients (p less than 0.1). It is concluded that ISDN has no place in the treatment of haemodynamically intact patients with severe angina pectoris in spite of beta-blocking treatment, but that it may be of value in the treatment of patients with left ventricular failure, including those whose left ventricular failure has been brought about by beta-blocking treatment necessitated by angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840163     DOI: 10.1007/bf00613812

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Increased exercise tolerance with nitrates in beta-blockaded patients with angina.

Authors:  R H Baxter; I M Lennox
Journal:  Br Med J       Date:  1977-08-27

Review 2.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

3.  Comparative evaluation of sublingual long-acting nitrates.

Authors:  A P Klaus; B L Zaret; B L Pitt; R S Ross
Journal:  Circulation       Date:  1973-09       Impact factor: 29.690

4.  Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris.

Authors:  D J Battock; H Alvarez; C A Chidsey
Journal:  Circulation       Date:  1969-02       Impact factor: 29.690

5.  Propranolol and isosorbide dinitrate synergism in angina pectoris.

Authors:  H I Russek
Journal:  Am J Cardiol       Date:  1968-01       Impact factor: 2.778

6.  Plasma concentrations of isosorbide dinitrate after administration of increasing doses of a sustained-release formulation to human subjects.

Authors:  T Taylor; D A O'Kelly; R M Major; A Darragh; L F Chasseaud
Journal:  Arzneimittelforschung       Date:  1978

7.  The effects of isoprenaline, atropine and dobutamine on ventricular volume curves obtained by radionuclide ventriculography.

Authors:  A L Muir; W J Hannan; R P Sapru; A K Boardman; P K Wraith; H M Brash
Journal:  Clin Sci (Lond)       Date:  1980-05       Impact factor: 6.124

8.  The long-acting hemodynamic effects of isosorbide dinitrate.

Authors:  T Sweatman; G Strauss; A Selzer; K E Cohn
Journal:  Am J Cardiol       Date:  1972-04       Impact factor: 2.778

9.  Therapy of angina pectoris with propranolol and long-acting nitrates.

Authors:  A N Goldbarg; J F Moran; T K Butterfield; R Nemickas; G A Bermudez
Journal:  Circulation       Date:  1969-12       Impact factor: 29.690

10.  The effect of pindolol and isosorbide dinitrate and their combination on exercise tolerance and ECG changes in angina pectoris.

Authors:  L Storstein
Journal:  Acta Med Scand       Date:  1981
View more
  2 in total

Review 1.  Combination and triple therapy in patients with stable angina pectoris not adequately controlled by optimal β-blocker therapy.

Authors:  W E M Kok; F C Visser; C A Visser
Journal:  Neth Heart J       Date:  2002-11       Impact factor: 2.380

2.  Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.

Authors:  A Uusitalo
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.